T1	Treatment 10 15	CX516
T2	Treatment 20 44	AMPA-modulating compound
T3	Treatment 161 179	placebo-controlled
T4	Treatment 252 260	Ampakine
T5	Treatment 270 275	CX516
T6	Treatment 423 516	1-week placebo lead-in and then were randomized to study drug or placebo for a 4-week period.
T7	Treatment 810 815	CX516
T8	Treatment 1053 1066	CX516-treated
T9	Treatment 1088 1096	placebo.
T10	Treatment 1439 1444	CX516
